Works matching AU Chan, Stephen L

Results: 73
    1

    Analysis by Treatment Period and Liver Function in EMERALD-1: Phase 3 Study of Durvalumab (D) With/Without Bevacizumab (B) With Transarterial Chemoembolization (TACE) in Unresectable Hepatocellular Carcinoma (uHCC) Eligible for Embolization.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 327
    By:
    • Chan, Stephen L.;
    • Kudo, Masatoshi;
    • Decaens, Thomas;
    • Erinjeri, Joseph P.;
    • Qin, Shukui;
    • Ren, Zhenggang;
    • Arai, Yasuaki;
    • Bouattour, Mohamed;
    • Breder, Valeriy V.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 321, doi. 10.1159/000529574
    By:
    • Kudo, Masatoshi;
    • Aoki, Tomoko;
    • Ueshima, Kazuomi;
    • Tsuchiya, Kaoru;
    • Morita, Masahiro;
    • Chishina, Hirokazu;
    • Takita, Masahiro;
    • Hagiwara, Satoru;
    • Minami, Yasunori;
    • Ida, Hiroshi;
    • Nishida, Naoshi;
    • Ogawa, Chikara;
    • Tomonari, Tetsu;
    • Nakamura, Noriaki;
    • Kuroda, Hidekatsu;
    • Takebe, Atsushi;
    • Takeyama, Yoshifumi;
    • Hidaka, Masaaki;
    • Eguchi, Susumu;
    • Chan, Stephen L
    Publication type:
    Article
    13
    14
    15
    16

    Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.

    Published in:
    2017
    By:
    • Leung Li;
    • Mo, Frankie K. F.;
    • Chan, Stephen L.;
    • Hui, Edwin P.;
    • Tang, Nelson S. L.;
    • Koh, Jane;
    • Leung, Linda K. S.;
    • Poon, Annette N. Y.;
    • Joyce Hui;
    • Chu, Cheuk M.;
    • Lee, Kit F.;
    • Ma, Brigette B. Y.;
    • Lai, Paul B. S.;
    • Chan, Anthony T. C.;
    • Yu, Simon C. H.;
    • Winnie Yeo;
    • Li, Leung;
    • Mo, Frankie Kf;
    • Tang, Nelson Sl;
    • Leung, Linda Ks
    Publication type:
    journal article
    17
    18
    19
    20
    21

    Issue Cover.

    Published in:
    Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
    By:
    • Galle, Peter R.;
    • Foerster, Friedrich;
    • Kudo, Masatoshi;
    • Chan, Stephen L.;
    • Llovet, Josep M.;
    • Qin, Shukui;
    • Schelman, William R.;
    • Chintharlapalli, Sudhakar;
    • Abada, Paolo B.;
    • Sherman, Morris;
    • Zhu, Andrew X.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02383-5
    By:
    • Chan, Stephen L.;
    • Schuler, Martin;
    • Kang, Yoon-Koo;
    • Yen, Chia-Jui;
    • Edeline, Julien;
    • Choo, Su Pin;
    • Lin, Chia-Chi;
    • Okusaka, Takuji;
    • Weiss, Karl-Heinz;
    • Macarulla, Teresa;
    • Cattan, Stéphane;
    • Blanc, Jean-Frederic;
    • Lee, Kyung-Hun;
    • Maur, Michela;
    • Pant, Shubham;
    • Kudo, Masatoshi;
    • Assenat, Eric;
    • Zhu, Andrew X.;
    • Yau, Thomas;
    • Lim, Ho Yeong
    Publication type:
    Article
    28

    Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 3, p. 2572, doi. 10.1002/cam4.5123
    By:
    • Bang, Kyunghye;
    • Casadei‐Gardini, Andrea;
    • Yoo, Changhoon;
    • Iavarone, Massimo;
    • Ryu, Min‐Hee;
    • Park, Sook Ryun;
    • Kim, Hyung‐Don;
    • Yoon, Young‐In;
    • Jung, Dong‐Hwan;
    • Park, Gil‐Chun;
    • Ahn, Chul‐Soo;
    • Moon, Deok‐Bog;
    • Hwang, Shin;
    • Kim, Ki‐Hun;
    • Song, Gi‐Won;
    • Mazzarelli, Chiara;
    • Alimenti, Eleonora;
    • Chan, Stephen L.;
    • De Giorgio, Massimo;
    • Ryoo, Baek‐Yeol
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma.

    Published in:
    Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 18, p. 10705, doi. 10.1111/jcmm.15691
    By:
    • Leung, Idy C.‐Y.;
    • Chong, Charing C.‐N.;
    • Cheung, Tan T.;
    • Yeung, Philip C.;
    • Ng, Kelvin K.‐C.;
    • Lai, Paul B.‐S.;
    • Chan, Stephen L.;
    • Chan, Anthony W.‐H.;
    • Tang, Patrick M.‐K.;
    • Cheung, Siu T.
    Publication type:
    Article
    45

    Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 11, p. 1991, doi. 10.1002/cncr.35226
    By:
    • Bishnoi, Sarwan;
    • Kotasek, Dusan;
    • Aghmesheh, Morteza;
    • Yau, Thomas;
    • Cosman, Rasha;
    • Prawira, Amy;
    • Moore, Maggie;
    • Chan, Stephen L.;
    • Mant, Andrew;
    • Eek, Richard;
    • Zielinski, Robert;
    • Su, Rila;
    • Pan, Zhaoxuan;
    • Ma, Yiding;
    • Li, Fei;
    • Li, Peiqi;
    • Tse, Archie N.
    Publication type:
    Article
    46

    Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 6, p. 865, doi. 10.1002/cncr.33317
    By:
    • Ryoo, Baek‐Yeol;
    • Merle, Philippe;
    • Kulkarni, Amit S.;
    • Cheng, Ann‐Lii;
    • Bouattour, Mohamed;
    • Lim, Ho Yeong;
    • Breder, Valeriy;
    • Edeline, Julien;
    • Chao, Yee;
    • Ogasawara, Sadahisa;
    • Yau, Thomas;
    • Garrido, Marcelo;
    • Chan, Stephen L.;
    • Daniele, Bruno;
    • Norquist, Josephine M.;
    • Chen, Erluo;
    • Siegel, Abby B.;
    • Zhu, Andrew X.;
    • Finn, Richard S.;
    • Kudo, Masatoshi
    Publication type:
    Article
    47
    48

    Methylation-Associated Nucleosomal Patterns of Cell-Free DNA in Cancer Patients and Pregnant Women.

    Published in:
    Clinical Chemistry, 2024, v. 70, n. 11, p. 1355, doi. 10.1093/clinchem/hvae118
    By:
    • Zhu, Guanhua;
    • Jiang, Peiyong;
    • Li, Xingqian;
    • Peng, Wenlei;
    • Choy, L Y Lois;
    • Yu, Stephanie C Y;
    • Zhou, Qing;
    • Ma, Mary-Jane L;
    • Kang, Guannan;
    • Bai, Jinyue;
    • Qiao, Rong;
    • Deng, Chian Xi Shirley;
    • Ding, Spencer C;
    • Lam, Wai Kei Jacky;
    • Chan, Stephen L;
    • Lau, So Ling;
    • Leung, Tak Y;
    • Wong, John;
    • Chan, K C Allen;
    • Lo, Y M Dennis
    Publication type:
    Article
    49
    50